
doi: 10.1038/ng.3796
pmid: 28232728
The ultimate goal of precision medicine is to use population-based molecular, clinical and other data to make individually tailored clinical decisions for patients, although the path to achieving this goal is not entirely clear. A new study shows how knowledge banks of patient data can be used to make individual treatment decisions in acute myeloid leukemia.
Databases, Factual, Clinical Decision-Making, Remission Induction, Hematopoietic Stem Cell Transplantation, Antineoplastic Agents, Medical Oncology, Survival Analysis, Leukemia, Myeloid, Acute, Humans, Precision Medicine
Databases, Factual, Clinical Decision-Making, Remission Induction, Hematopoietic Stem Cell Transplantation, Antineoplastic Agents, Medical Oncology, Survival Analysis, Leukemia, Myeloid, Acute, Humans, Precision Medicine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 12 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
